The sweet mysteries of the nervous system

May 10, 2011
Two types of stem cells were stained with the new Bochum antibody 5750 (red) and the conventional antibody 487 (green). They can be clearly separated, since the antibodies recognise different LewisX sugar residues. (c) American Society for Biochemistry and Molecular Biology. Credit: RUB

Researchers in Germany have produced an antibody that allows them to distinguish the numerous types of stem cells in the nervous system better than before.

"In order to use stem cells for therapeutic purposes, it is important to be able to distinguish between the different types", explained Eva Hennen of the RUB Department of and Molecular Neurobiology (Faculty of Biology and Biotechnology).

The antibody 5750 recognises a specific sugar residue on the cell surface, which is called LewisX. The research group lead by Prof. Dr. Andreas Faissner has now been able to use LewisX for the first time to separate different types of stem cells. The researchers report on their results in the .

Unexpected sugar diversity

Antibodies that recognise the LewisX sugar residue are used routinely to identify so-called neural stem cells from which the various cells of the nervous system originate. Prof. Faissner's team has now shown that the designation "LewisX" does not just cover a single sugar motif, but a whole range of different sugar residues. Different types of neural stem cells are equipped with individual combinations of LewisX sugar residues on their cell surface. The new Bochum antibody 5750 recognises a different LewisX sugar residue to the antibodies previously used. "This sugar diversity could also be interesting for " Prof. Faissner explained, "because LewisX sugars have also been detected on ".

Identifying properties of stem cells

With the aid of the new antibody 5750, certain types of can be isolated from a mixture of different cell types. The aim of Prof. Faissner's research group is now to examine the properties of the stem cells which carry the LewisX sugar residues. The researchers have already found out that the LewisX motif on the changes when the stem cells develop further – for example into oligodendrocytes, which form the insulation layer of the nerve cells, or into nerve cells themselves.

Explore further: Jumping hurdles in the RNA world

More information: Hennen E, Czopka T, Faissner A (2011) Structurally Distinct LewisX Glycans Distinguish Subpopulations of Neural Stem/Progenitor Cells. The Journal of Biological Chemistry 286: 16321-16331. doi 10.1074/jbc.M110.201095

Provided by Ruhr-University Bochum

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Sweet success for new stem cell ID trick

Nov 20, 2008

(PhysOrg.com) -- Biomaterial scientists in Manchester believe they have found a new way of isolating the ‘ingredients’ needed for potential stem cell treatments for nerve damage and heart disease.

New study hopeful on neural stem cells

Aug 05, 2006

Neural stem cells derived from federally approved human embryonic cells are inferior to stem cells derived from donated fetal tissue, a new study found.

When is a stem cell not really a stem cell?

Aug 26, 2007

Working with embryonic mouse brains, a team of Johns Hopkins scientists seems to have discovered an almost-too-easy way to distinguish between “true” neural stem cells and similar, but less potent versions. Their finding, ...

Recommended for you

Molecules that came in handy for first life on Earth

11 hours ago

For the first time, chemists have successfully produced amino acid-like molecules that all have the same 'handedness', from simple building blocks and in a single test tube. Could this be how life started. ...

Jumping hurdles in the RNA world

Nov 21, 2014

Astrobiologists have shown that the formation of RNA from prebiotic reactions may not be as problematic as scientists once thought.

New computer model sets new precedent in drug discovery

Nov 18, 2014

A major challenge faced by the pharmaceutical industry has been how to rationally design and select protein molecules to create effective biologic drug therapies while reducing unintended side effects - a challenge that has ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.